Imunon (IMNN) Goodwill & Intangibles (2010 - 2022)
Imunon's (IMNN) quarterly Goodwill & Intangibles came in at $1.6 million in Q4 2022, down 89.59% YoY from $15.4 million in Q4 2021, and down 89.61% on a QoQ basis from $15.4 million in Q3 2022.
Imunon (IMNN) Goodwill & Intangibles (2010 - 2022) Analysis & Trends
Imunon (IMNN) has 13 years of Goodwill & Intangibles data on file, last reported at $1.6 million in Q4 2022.
- Quarterly Goodwill & Intangibles fell 89.59% year-over-year to $1.6 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $1.6 million (down 89.59% YoY) and the FY2022 annual result came in at $1.6 million, down 89.59% from the prior year.
- Goodwill & Intangibles retreated to $1.6 million in Q4 2022, from $15.4 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $17.7 million in Q1 2019 to a low of $1.6 million in Q4 2022.
- A 5-year average of $9.5 million and a median of $9.6 million in 2019 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2021 — Goodwill & Intangibles soared 575.86% — and 2022, when it slumped 89.59%.
- Tracing IMNN's Goodwill & Intangibles over 5 years: stood at $2.5 million in 2018, then surged by 55.33% to $4.0 million in 2019, then changed by 0.0% to $4.0 million in 2020, then jumped by 288.8% to $15.4 million in 2021, then tumbled by 89.59% to $1.6 million in 2022.
- The last three Goodwill & Intangibles figures came in at $1.6 million (Q4 2022), $15.4 million (Q3 2022), and $15.4 million (Q2 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Imunon | 8.42 Mn | 8.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 1.60 Mn |
| Sep 30, 2022 | 15.40 Mn |
| Jun 30, 2022 | 15.37 Mn |
| Mar 31, 2022 | 3.60 Mn |
| Dec 31, 2021 | 15.37 Mn |
| Sep 30, 2021 | 15.28 Mn |
| Jun 30, 2021 | 15.37 Mn |
| Mar 31, 2021 | 15.28 Mn |
| Dec 31, 2020 | 3.95 Mn |
| Sep 30, 2020 | 15.34 Mn |
| Jun 30, 2020 | 17.71 Mn |
| Mar 31, 2020 | 2.26 Mn |
| Dec 31, 2019 | 3.95 Mn |
| Sep 30, 2019 | 3.60 Mn |
| Jun 30, 2019 | 17.74 Mn |
| Mar 31, 2019 | 17.74 Mn |
| Dec 31, 2018 | 2.54 Mn |
| Sep 30, 2018 | 2.60 Mn |
| Jun 30, 2018 | 2.66 Mn |
| Mar 31, 2018 | 2.71 Mn |